Mitomycin C plus Infusional 5-Fluorouracil in Platinum-Refractory Gastric Adenocarcinoma: An Extended Multicenter Phase II Study-Reference-Cited by-同舟云学术

Mitomycin C plus Infusional 5-Fluorouracil in Platinum-Refractory Gastric Adenocarcinoma: An Extended Multicenter Phase II Study

Published:2007 Issue:5 Volume:30 Page:235-240
ISSN:2296-5270
Container-title:Oncology Research and Treatment
language:en
Short-container-title:Oncol Res Treat

Author:

Hartmann Jörg Thomas,Pintoffl Jan Peter,Al-Batran Salah-Eddin,Quietzsch Detlef,Meisinger Ines,Horger Marius,Nehls Oliver,Bokemeyer Carsten,Königsrainer Alfred,Jäger Elke,Kanz Lothar

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology

Reference25 articles.

1. Mitomycin C Therapy in Advanced Gastrointestinal Cancer

2. Clinical management of advanced gastrointestinal cancer

3. Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

4. Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer

5. Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group;Annals of Gastroenterology;2017

2. Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?;Journal of the National Comprehensive Cancer Network;2015-10

3. Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study;Journal of Cancer Research and Clinical Oncology;2014-02-21

4. The Role of Chemotherapy in Metastatic Disease;Surgery in the Multimodal Management of Gastric Cancer;2012

5. A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial);Gastric Cancer;2011-04-19